SCHEMBL24286745

SCHEMBL24286745

CC[S+]([O-])c1ccc(-c2cccc(F)c2)nc1-c1nc2cc(C(F)(F)F)ncc2n1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 2/20 0.35
▸ MAP4K4 O95819 5/20 0.34
▸ PTGS1 P23219 1/20 0.33
▸ CYP11B1 P15538 1/20 0.32
▸ CYP11B2 P19099 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ CYP1A2 P05177 2/20 0.32
▸ USP2 O75604 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ CLK4 Q9HAZ1 1/20 0.32
▸ MET P08581 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24286076 0.86 TP53 (0.33) PTGS2PTGS1ALDH1A1KDM4EMAPT
SCHEMBL24286246 0.84 GRM5 (0.35) —
SCHEMBL24286744 0.83 MAP4K4 (0.36) PTGS2MAP4K4PTGS1CYP11B1CYP11B2
SCHEMBL19725904 0.82 PTGS2 (0.39) PTGS2MAP4K4PTGS1CYP11B1CYP11B2
SCHEMBL24286075 0.82 MEN1 (0.32) CYP11B1CYP11B2MEN1KMT2A
SCHEMBL17697064 0.81 PTGS2 (0.35) PTGS2CYP11B1CYP11B2KDM4E
SCHEMBL24286108 0.78 S1PR1 (0.31) —
SCHEMBL24286100 0.78 — —
SCHEMBL17949447 0.77 PDE10A (0.35) —
SCHEMBL24286101 0.76 ALOX5AP (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3247712-B1 PESTICIDALLY ACTIVE POLYCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS SYNGENTA PARTICIPATIONS AG (CH) 2022-04-20 — — EP disclosed
Send feedback